Innovation Policy for a New Era

Journal of Law, Medicine and Ethics 37 (2):264-268 (2009)
  Copy   BIBTEX

Abstract

This commentary offers a response to the Sonderholm, Bird, and Flynn et al. articles, and argues that the current innovation crisis requires more ambitious approaches, as well as a serious consideration of alternative mechanisms for R&D such as prizes.

Other Versions

No versions found

Links

PhilArchive



    Upload a copy of this work     Papers currently archived: 101,667

External links

Setup an account with your affiliations in order to access resources via your University's proxy server

Through your library

Similar books and articles

Business Research, Development, and Innovations in Economic Recession.Karel Mráček - 2009 - Teorie Vědy / Theory of Science 31 (3-4):263-294.
Situation of the R&D Sector in Poland in the Face of the Current Crisis.Kinga Karpińska - 2021 - Studies in Logic, Grammar and Rhetoric 66 (4):409-424.
why responsible innovation.Rene Von Schomberg - 2019 - In René von Schomberg & Jonathan Hankins (eds.), International Handbook on Responsible Innovation. A global resource. Cheltenham, Royaume-Uni: Edward Elgar Publishing. pp. 12-32.
Pharmaceutical Innovation in Latin America and the Caribbean.Verónica Vargas & Jonathan Darrow - 2023 - Journal of Law, Medicine and Ethics 51 (S1):148-162.

Analytics

Added to PP
2010-09-13

Downloads
35 (#651,090)

6 months
8 (#603,286)

Historical graph of downloads
How can I increase my downloads?

Citations of this work

Pharmaceutical Innovation: Law & the Public's Health.Kevin Outterson - 2009 - Journal of Law, Medicine and Ethics 37 (2):173-175.

Add more citations